» Articles » PMID: 32342597

Plasma Rich in Growth Factors Reduces Blue Light-induced Oxidative Damage on Retinal Pigment Epithelial Cells and Restores Their Homeostasis by Modulating Vascular Endothelial Growth Factor and Pigment Epithelium-derived Factor Expression

Overview
Specialty Ophthalmology
Date 2020 Apr 29
PMID 32342597
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study analysed the effectiveness of plasma rich in growth factors (PRGF) in reducing the oxidative stress induced by blue light exposition on retinal pigment epithelial (RPE) cells.

Methods: Blood from six healthy donors was collected to obtain the PRGF. Retinal pigment epithelium (ARPE-19) cells were exposed to blue light. Then, cells were incubated with PRGF or with control for 24 and 48 hours maintaining exposure to blue light. The cytoprotective effect of PRGF on ARPE cells was evaluated by measuring the cell viability, the reactive oxygen species (ROS) production and the expression of different proteins such as heme oxygenase 1 (HO-1), catalase (CAT), superoxide dismutase (SOD-1), apoptosis-inducing factor (AIF), pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF).

Results: The cell viability increased significantly at 24 and 48 hours after PRGF treatment compared to the control group. ROS synthesis was significantly reduced in PRGF-treated cells with respect to control. Furthermore, the levels of HO-1, SOD-1 and AIF were significantly reduced after PRGF treatment at both times of treatment. However, CAT levels were only significantly reduced after PRGF treatment at 48 hours. The high expression of VEGF by RPE cells exposed to blue light was only counterbalanced in the PRGF group by increasing the expression of PEDF in comparison to the control group.

Conclusion: The present results show that PRGF treatment reduces the cytotoxic effects induced in RPE cells exposed to an oxidative stress environment. Furthermore, PRGF treatment preserves the mitochondrial activity and cell viability of RPE cells subjected to an oxidative stress.

Citing Articles

Potential Use of Plasma Rich in Growth Factors in Age-Related Macular Degeneration: Evidence from a Mouse Model.

Anitua E, Muruzabal F, Recalde S, Fernandez-Robredo P, Alkhraisat M Medicina (Kaunas). 2025; 60(12.

PMID: 39768916 PMC: 11727663. DOI: 10.3390/medicina60122036.


Unveiling the role of CaMKII in retinal degeneration: from biological mechanism to therapeutic strategies.

Sun Y, Hao M, Wu H, Zhang C, Wei D, Li S Cell Biosci. 2024; 14(1):59.

PMID: 38725013 PMC: 11084033. DOI: 10.1186/s13578-024-01236-2.


PRGF Membrane with Tailored Optical Properties Preserves the Cytoprotective Effect of Plasma Rich in Growth Factors: In Vitro Model of Retinal Pigment Epithelial Cells.

Anitua E, Muruzabal F, Fuente M, Del Olmo-Aguado S, Alkhraisat M, Merayo-Lloves J Int J Mol Sci. 2023; 24(13).

PMID: 37446374 PMC: 10342881. DOI: 10.3390/ijms241311195.


Combined Therapy with Laser and Autologous Topical Serum for Facial Rejuvenation: A Multiple Case Series Report.

Navarro R, Pino A, Martinez A, Garrigos E, Grau M, Gallego E J Cutan Aesthet Surg. 2023; 15(4):363-370.

PMID: 37035594 PMC: 10081471. DOI: 10.4103/JCAS.JCAS_159_21.


An Autologous Topical Serum Derived from Platelet-Rich Plasma Therapy for the Management of Sensitive Skin Alterations: A Case Series Report.

Garcia-Millan C, Pino A, Rodrigues R, Segurado-Miravalles G, Alegre-Sanchez A, Jaen P Clin Cosmet Investig Dermatol. 2022; 15:2077-2086.

PMID: 36199385 PMC: 9528915. DOI: 10.2147/CCID.S379323.